Radiofrequency Ablation versus Surgical Resection in Elderly Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Current Oncology · 06.01.2024 · 31 (1) · 324-334
DOI: 10.3390/curroncol31010021 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Current Oncology, online erschienen am 06.01.2024. Verfasst von Jeong-Ju Yoo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Soonchunhyang University School of Medicine, Bucheon 14584, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Radiofrequency Ablation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Evidenc- based healthcare Collaborating Agency, Soonchunhyang University, National Evidence-based Healthcare Collaborating Agency (NECA).
Abstract (Originalsprache)
Although the disease burden of elderly cancer patients is rapidly increasing, reliable scientific information, value and preference information of domestic patients, and standardized guidelines for determining the treatment of elderly cancer patients are lacking. The aim of this study is to compare the therapeutic effects of radiofrequency ablation (RFA) and surgery in hepatocellular carcinoma (HCC) patients aged 65 years or older. For the meta-analysis, the databases including PubMed (MEDLINE), EMBASE, OVID Medline, and the Cochrane Library were systematically searched. After the abstract-based review by two investigators, selected manuscripts were read in detail. The surgery group showed higher overall survival (OS) (HR 1.44, 95% CI 1.22–1.70) and disease-free survival (DFS) (HR 1.40, 95% CI 1.00–1.97) than the RFA group. This was also shown in small HCC of less than 3 cm (OS, HR 1.42, 95% CI 1.00–2.03; DFS, HR 1.32, 95% CI 0.91–1.91). This might be related to the high local recurrence in the RFA group (OR 4.90, 95% 2.16–11.08). On the other hand, adverse events were significantly lower in the RFA group (OR 0.22, 95% CI 0.14–0.36), which led to a decrease in the duration of hospital stay (mean difference −14.88 days, 95% CI −22.44–−7.32). In elderly HCC patients, survival in the surgery group was significantly higher than in the RFA group, but various complications tended to increase; so, appropriate patient selection is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Soonchunhyang University School of Medicine, Bucheon 14584, Republic of Korea.
- Graduate School of Converging Clinical and Public Health, Ewha Womans University, Seoul 03760, Republic of Korea.
- Department of General Surgery, Yonsei University School of Medicine, Seoul 03722, Republic of Korea.
- Department of Radiology, Samgsung Medical Center, Sungkyunkwan University, Seoul 06171, Republic of Korea.
- Division of Healthcare Technology Assessment Research, National Evidence-Based Healthcare Collaborating Agency, Seoul 04933, Republic of Korea.
ORCID-Profile: Jeong-Ju Yoo, Seungeun Ryoo
Förderung
- National Evidenc- based healthcare Collaborating Agency
- Soonchunhyang University
- National Evidence-based Healthcare Collaborating Agency (NECA)
- Soonchunhyang University Research Fund
Zitieren
APA
Yoo, J. J., Koo, S., Choi, G. H., Lee, M. W., Ryoo, S., Park, J., & Park, D. A. (2024). Radiofrequency Ablation versus Surgical Resection in Elderly Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Current Oncology, 31(1), 324-334. https://doi.org/10.3390/curroncol31010021
Vancouver
Yoo JJ, Koo S, Choi GH, Lee MW, Ryoo S, Park J, et al. Radiofrequency Ablation versus Surgical Resection in Elderly Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Current Oncology. 2024;31(1):324-334. doi:10.3390/curroncol31010021
BibTeX
@article{Yoo2024,
author = {Yoo, Jeong-Ju and Koo, Sujin and Choi, Gi Hong and Lee, Min Woo and Ryoo, Seungeun and Park, Jungeun and Park, Dong Ah},
title = {Radiofrequency Ablation versus Surgical Resection in Elderly Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis},
journal = {Current Oncology},
year = {2024},
volume = {31},
number = {1},
pages = {324--334},
doi = {10.3390/curroncol31010021}
}
EUVIMED